WIT Program
Cima Universidad de Navarra
Advance in your career by participating in research projects where you can complete an innovative doctoral thesis.
Learn about the projects at
Cima Universidad de Navarra
Discover how you can develop an innovative doctoral thesis
Myeloma and monoclonal gammopathies
Objective:
To identify the plasma cell clone responsible for dissemination, resistance, and relapse, by studying circulating tumor cells (CTC) and minimal residual disease (MRD).
| Dr. Bruno Paiva Principal Investigator Multiple Myeloma Research Group |
CAR T therapies for hematologic malignancies and solid tumors
Objective:
Develop innovative CAR T therapies and Dissect the molecular mechanisms involved in the antitumor response, resistance, and toxicities associated with these therapies.
| Dr. Felipe Prósper Principal Investigator Adoptive Cell Therapy Research Group Molecular basis of hematologic malignancies |
Advanced therapies for pediatric solid tumors
Objective:
To develop new therapeutic strategies for childhood brain tumors and sarcomas, exploiting the immune system by using tumor-specific oncolytic adenoviruses and combining them with other strategies that can enhance that effect.
|
Dr. Marta Alonso |
Deciphering the molecular profile of heart failure with preserved ejection fraction (HFpEF)
Objective:
To exploit the potential of blood liquid biopsy in patients with ICFEP, to evaluate the pathophysiological role of targets identified in vitro and in vivo studies and in cardiac biopsies from these patients, and to validate the clinical utility of biomarkers in combination with state-of-the-art MRI analysis in patients with ICFEP.
|
Dra. Arantxa González Miqueo |
Gene therapy for rare diseases
Objective::
To study liver diseases of genetic origin with no alternative curative treatment to liver transplantation and to develop new therapeutic strategies based on gene transfer and gene editing gene transfer and gene editing.
|
Dra. Gloria González Aseguinolaza |
Gene therapy for Parkinson's disease
Objective:
To develop gene therapy tools with viral vectors both to achieve better animal models of Parkinson's disease and with therapeutic perspectives to modify the progressive course of this neurodegenerative process.
|
Dr. José Luis Lanciego |
Gene regulation in cancer
Objective:
Study the role of long non-coding RNAs (lncRNAs) in genomic stability and cancer by combining experimental and genomic techniques and the latest methodology for the functional study of lncRNAs in cancer.
|
Dra. Maite Huarte |
Hepatic carcinogenesis
Objective:
To study epigenetic and post-transcriptional processes that modulate gene expression and contribute to liver injury and carcinogenesis.
|
Dr. Matías Ávila |
Cancer immunotherapy
Objective:
To study cancer immunotherapy based on bifunctional immunostimulatory molecules expressed by modified mRNA.
|
Dr. Pedro Berraondo |